ID   AA1R_CAVPO     STANDARD;      PRT;   326 AA.
AC   P47745;
DT   01-FEB-1996 (Rel. 33, Created)
DT   01-FEB-1996 (Rel. 33, Last sequence update)
DT   15-JUL-1998 (Rel. 36, Last annotation update)
DE   Adenosine A1 receptor.
GN   ADORA1.
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Rodentia; Hystricognathi; Caviidae; Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   SEQUENCE FROM N.A.
RC   STRAIN=Hartley; TISSUE=Brain;
RX   MEDLINE=95157167; PubMed=7854041;
RA   Meng F., Xie G.X., Chalmers D., Morgan C., Watson S.J. Jr., Akil H.;
RT   "Cloning and characterization of a pharmacologically distinct A1
RT   adenosine receptor from guinea pig brain.";
RL   Brain Res. Mol. Brain Res. 26:143-155(1994).
CC   -!- FUNCTION: RECEPTOR FOR ADENOSINE. THE ACTIVITY OF THIS RECEPTOR
CC       IS MEDIATED BY G PROTEINS WHICH INHIBIT ADENYLYL CYCLASE.
CC   -!- SUBCELLULAR LOCATION: Integral membrane protein.
CC   -!- SIMILARITY: BELONGS TO FAMILY 1 OF G-PROTEIN COUPLED RECEPTORS.
CC   --------------------------------------------------------------------------
CC   This SWISS-PROT entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use  by  non-profit  institutions as long  as its content  is  in  no  way
CC   modified and this statement is not removed.  Usage  by  and for commercial
CC   entities requires a license agreement (See http://www.isb-sib.ch/announce/
CC   or send an email to license@isb-sib.ch).
CC   --------------------------------------------------------------------------
DR   EMBL; U04279; AAB60505.1; -.
DR   HSSP; P29274; 1MMH.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
KW   G-protein coupled receptor; Transmembrane; Glycoprotein;
KW   Lipoprotein; Palmitate.
FT   DOMAIN        1     10       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM     11     33       1 (POTENTIAL).
FT   DOMAIN       34     46       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM     47     69       2 (POTENTIAL).
FT   DOMAIN       70     80       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM     81    102       3 (POTENTIAL).
FT   DOMAIN      103    123       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    124    146       4 (POTENTIAL).
FT   DOMAIN      147    176       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    177    201       5 (POTENTIAL).
FT   DOMAIN      202    235       CYTOPLASMIC (POTENTIAL).
FT   TRANSMEM    236    259       6 (POTENTIAL).
FT   DOMAIN      260    267       EXTRACELLULAR (POTENTIAL).
FT   TRANSMEM    268    292       7 (POTENTIAL).
FT   DOMAIN      293    326       CYTOPLASMIC (POTENTIAL).
FT   DISULFID     80    169       BY SIMILARITY.
FT   CARBOHYD    159    159       N-LINKED (GLCNAC...) (POTENTIAL).
FT   LIPID       309    309       PALMITATE (POTENTIAL).
SQ   SEQUENCE   326 AA;  36492 MW;  A2E8D594F5D6A233 CRC64;
     MPHSVSAFQA AYIGIEVLIA LVSVPGNVLV IWAVKVNQAL RDATFCFIAS LAVADVAVGA
     LVIPLAILIN IGPQTYFHTC LMVACPVLIL TQSSILALLA IAVDRYLRVK IPLRYKTVVT
     PRRAAVAIAG CWILSLVVGL TPMFGWNNLS KIEMAWAANG SVGEPVIKCE FEKVISMEYM
     VYFNFFVWVL PPLLLMVLIY LEVFYLIRKQ LSKKVSASSG DPQKYYGKEL KIAKSLALIL
     FLFALSWLPL HILNCITLFC PTCHKPTILT YIAIFLTHGN SAMNPIVYAF RIQKFRVTFL
     KIWNDHFRCQ PEPPIDEDLP EEKVDD
//